Stocks
Elanco Animal Health Financial Statements (ELAN) |
||||||||||
| Elanco Animal Healthsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 28.02.2020 | 01.03.2021 | 28.02.2022 | 01.03.2023 | 26.02.2024 | 07.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 3 071 | 3 273 | 4 765 | 4 418 | 4 417 | 4 454 | |||
| Operating Income, bln rub | 342.6 | 101.5 | 297.0 | 358.0 | 326.0 | 219.0 | ||||
| EBITDA, bln rub | ? | 471.6 | -76.8 | 409.0 | 866.0 | -224.0 | 600.0 | |||
| Net profit, bln rub | ? | 67.9 | -560.1 | -472.0 | -74.0 | -1 231 | 205.0 | |||
| OCF, bln rub | ? | 224.1 | -41.0 | 483.0 | 452.0 | 271.0 | 521.0 | |||
| CAPEX, bln rub | ? | 197.4 | 310.9 | 197.0 | 184.0 | 154.0 | 141.0 | |||
| FCF, bln rub | ? | 26.7 | -351.9 | 286.0 | 268.0 | 117.0 | 380.0 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 1 231 | 1 684 | 2 329 | 2 115 | 1 612 | 1 919 | ||||
| Cost of production, bln rub | 1 470 | 1 667 | 2 134 | 1 913 | 1 931 | 2 282 | ||||
| R&D, bln rub | 270.1 | 327.0 | 369.0 | 321.0 | 327.0 | 342.0 | ||||
| Interest expenses, bln rub | 78.9 | 149.8 | 236.0 | 241.0 | 277.0 | 256.0 | ||||
| Assets, bln rub | 8 986 | 17 693 | 16 483 | 15 491 | 14 362 | 13 283 | ||||
| Net Assets, bln rub | ? | 5 547 | 8 476 | 7 538 | 7 289 | 6 223 | 6 523 | |||
| Debt, bln rub | 2 355 | 6 127 | 6 319 | 5 836 | 5 774 | 4 357 | ||||
| Cash, bln rub | 334.0 | 494.7 | 638.0 | 345.0 | 352.0 | 490.0 | ||||
| Net debt, bln rub | 2 021 | 5 632 | 5 681 | 5 491 | 5 422 | 3 867 | ||||
| Ordinary share price, rub | 29.5 | 30.7 | 28.4 | 12.2 | 14.9 | 9.38 | ||||
| Number of ordinary shares, mln | 369.0 | 441.4 | 487.2 | 488.3 | 492.3 | 494.3 | ||||
| Market cap, bln rub | 10 867 | 13 538 | 13 827 | 5 967 | 7 335 | 4 637 | ||||
| EV, bln rub | ? | 12 888 | 19 170 | 19 508 | 11 458 | 12 757 | 8 504 | |||
| Book value, bln rub | 75 | -4 136 | -4 221 | -3 546 | -3 365 | -2 113 | ||||
| EPS, rub | ? | 0.18 | -1.27 | -0.97 | -0.15 | -2.50 | 0.41 | |||
| FCF/share, rub | 0.07 | -0.80 | 0.59 | 0.55 | 0.24 | 0.77 | ||||
| BV/share, rub | 0.20 | -9.37 | -8.66 | -7.26 | -6.84 | -4.27 | ||||
| EBITDA margin, % | ? | 15.4% | -2.35% | 8.58% | 19.6% | -5.07% | 13.5% | |||
| Net margin, % | ? | 2.21% | -17.1% | -9.91% | -1.67% | -27.9% | 4.60% | |||
| FCF yield, % | ? | 0.25% | -2.60% | 2.07% | 4.49% | 1.60% | 8.20% | |||
| ROE, % | ? | 1.22% | -6.61% | -6.26% | -1.02% | -19.8% | 3.14% | |||
| ROA, % | ? | 0.76% | -3.17% | -2.86% | -0.48% | -8.57% | 1.54% | |||
| P/E | ? | 160.0 | -24.2 | -29.3 | -80.6 | -5.96 | 22.6 | |||
| P/FCF | 407.0 | -38.5 | 48.3 | 22.3 | 62.7 | 12.2 | ||||
| P/S | ? | 3.54 | 4.14 | 2.90 | 1.35 | 1.66 | 1.04 | |||
| P/BV | ? | 145.9 | -3.27 | -3.28 | -1.68 | -2.18 | -2.19 | |||
| EV/EBITDA | ? | 27.3 | -249.6 | 47.7 | 13.2 | -57.0 | 14.2 | |||
| Debt/EBITDA | 4.29 | -73.3 | 13.9 | 6.34 | -24.2 | 6.45 | ||||
| R&D/CAPEX, % | 136.8% | 105.2% | 187.3% | 174.5% | 212.3% | 242.6% | ||||
| CAPEX/Revenue, % | 6.43% | 9.50% | 4.13% | 4.16% | 3.49% | 3.17% | ||||
| Elanco Animal Health shareholders | ||||||||||
